Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
alberta.ateere@paediatrics.ox.ac.uk

Alberta Ateere

Recent publications

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.

Drennan PG. et al, (2025), Lancet Microbe, 6

Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

Korompis M. et al, (2025), Sci Rep, 15

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis.

De Voss CJ. et al, (2025), Front Immunol, 16

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection study.

Jackson S. et al, (2024), Lancet Microbe, 5, 655 - 668

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults.

Fredsgaard-Jones T. et al, (2024), Front Immunol, 15

More publications